Variant report
Variant | esv15585 |
---|---|
Chromosome Location | chr21:46654099-46654729 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:16)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:16 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr21:46654455-46654552 | H1-hESC | embryonic stem cell: | n/a | chr21:46654501-46654519 chr21:46654504-46654517 |
2 | EGR1 | chr21:46654035-46654301 | GM12878 | blood: | n/a | chr21:46654193-46654207 |
3 | EGR1 | chr21:46654451-46654729 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | EGR1 | chr21:46653982-46654312 | K562 | blood: | n/a | chr21:46654193-46654207 |
5 | EGR1 | chr21:46654362-46654734 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | EGR1 | chr21:46653973-46654276 | K562 | blood: | n/a | chr21:46654193-46654207 |
7 | ELF1 | chr21:46654007-46654271 | K562 | blood: | n/a | chr21:46654216-46654229 chr21:46654190-46654203 chr21:46654203-46654216 |
8 | ELF1 | chr21:46653998-46654585 | GM12878 | blood: | n/a | chr21:46654216-46654229 chr21:46654190-46654203 chr21:46654203-46654216 |
9 | ELF1 | chr21:46654024-46654341 | K562 | blood: | n/a | chr21:46654216-46654229 chr21:46654190-46654203 chr21:46654203-46654216 |
10 | GABPA | chr21:46653994-46654497 | K562 | blood: | n/a | n/a |
11 | POLR2A | chr21:46654173-46655132 | Hela-S3 | cervix: | n/a | n/a |
12 | YY1 | chr21:46654059-46654394 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | YY1 | chr21:46654044-46654253 | GM12878 | blood: | n/a | n/a |
14 | YY1 | chr21:46654028-46654286 | K562 | blood: | n/a | n/a |
15 | YY1 | chr21:46654091-46654367 | K562 | blood: | n/a | n/a |
16 | ZNF143 | chr21:46654234-46654304 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ADARB1-2 | chr21:46654267-46654421 | XLOC_013979 |
2 | lnc-ADARB1-2 | chr21:46654255-46654391 | ENSG00000182586.3 |
No data |
No data |
Variant related genes | Relation type |
---|---|
LINC00334 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539585129 | chr21:46654099-46654100 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs551518461 | chr21:46654120-46654121 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs569918400 | chr21:46654128-46654129 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs386819273 | chr21:46654146-46654147 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs114952736 | chr21:46654147-46654148 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs533038566 | chr21:46654157-46654158 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs373194401 | chr21:46654161-46654162 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs574304548 | chr21:46654165-46654166 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs537988669 | chr21:46654172-46654173 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs556298207 | chr21:46654176-46654177 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs201799986 | chr21:46654180-46654181 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs185758223 | chr21:46654181-46654182 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs373305618 | chr21:46654184-46654185 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs67985055 | chr21:46654193-46654194 | Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs554903137 | chr21:46654218-46654219 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs535117866 | chr21:46654223-46654224 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs56974964 | chr21:46654230-46654231 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs57618026 | chr21:46654271-46654272 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs145973743 | chr21:46654272-46654273 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs575362395 | chr21:46654286-46654287 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs138559305 | chr21:46654292-46654293 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs189325206 | chr21:46654316-46654317 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs116518215 | chr21:46654336-46654337 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs180946290 | chr21:46654349-46654350 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs116390406 | chr21:46654381-46654382 | Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs185124573 | chr21:46654406-46654407 | Weak transcription Active TSS Bivalent/Poised TSS | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs3753016 | chr21:46654418-46654419 | Weak transcription Active TSS Bivalent/Poised TSS | lncRNA | n/a | Overlapped CNVs | mRNA abundance |
28 | rs573483445 | chr21:46654433-46654434 | Weak transcription Active TSS Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78073745 | chr21:46654442-46654443 | Weak transcription Active TSS Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530989940 | chr21:46654481-46654482 | Weak transcription Active TSS Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113711576 | chr21:46654511-46654512 | Weak transcription Active TSS Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567855313 | chr21:46654569-46654570 | Weak transcription Active TSS Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528516900 | chr21:46654602-46654603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115739106 | chr21:46654612-46654613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs3753017 | chr21:46654629-46654630 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs3753018 | chr21:46654647-46654648 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs116611521 | chr21:46654665-46654666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557075142 | chr21:46654709-46654710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6518219 | chr21:46654717-46654718 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 23341502 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Cholangiocarcinoma | 16830362 | CNVD |
Down syndrome | 17334655 | CNVD |
Neuroticism | 17667963 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Autoimmune polyendocrine syndrome | 18200029 | CNVD |
Prostate cancer | 19363497 | CNVD |
Lung cancer | 17086460 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Multiple myeloma | 16616336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:46637800-46668600 | Weak transcription | Right Atrium | heart |
2 | chr21:46643800-46664600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr21:46648800-46654200 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
4 | chr21:46648800-46654600 | Weak transcription | Fetal Brain Male | brain |
5 | chr21:46648800-46656400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr21:46652200-46654800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
7 | chr21:46652800-46655800 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
8 | chr21:46654000-46654200 | Bivalent/Poised TSS | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr21:46654000-46654400 | Flanking Bivalent TSS/Enh | Placenta | Placenta |
10 | chr21:46654000-46654400 | Active TSS | GM12878-XiMat | blood |
11 | chr21:46654000-46654600 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr21:46654200-46654400 | Bivalent/Poised TSS | Primary T cells fromperipheralblood | blood |
13 | chr21:46654200-46654600 | Active TSS | Primary T helper cells fromperipheralblood | blood |
14 | chr21:46654600-46655200 | Enhancers | Fetal Brain Male | brain |